Kara Egan

You might be skipping a test that could save your life.

One in four women in the U.S. aren’t up-to-date on cervical cancer screening.

Why? Because it’s time-consuming.

It’s an uncomfortable hassle.

Sometimes it’s even painful.

But Kara Egan, CEO of Teal Health, is on a mission to change that.

Her solution? The Teal Wand, the first FDA-approved, at-home cervical cancer screening test in the U.S.

No speculums.

No stirrups.

No crowded waiting rooms.

Just a simple, accurate test you can take in the comfort of your home.

“Women aren’t avoiding screenings because they don’t care about their health. They’re avoiding them because the system wasn’t designed with their lives in mind.”

And she would know.

As a health tech veteran, a mom of two, and a daughter caring for an aging parent, Kara has seen firsthand how women’s health gets pushed aside.

But under her leadership, Teal Health is rewriting that story:
The Teal Wand, a 96%-accurate at-home test, just received FDA approval and is now cleared for U.S. women.

Covered by major insurers like Aetna, Cigna, and Blue Cross.

Backed by top investors, including Serena Ventures and Emerson Collective.

Teal Health’s approach is already making waves.

Women who try the Teal Wand are more likely to stay up-to-date on their screenings, with 94% preferring it over traditional in-office testing.